InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the full record of transactions filed by Galimi Francesco, SVP et Directeur Médical. Officer active across 1 companies, notably Adicet Bio, Inc.. Cumulatively, 8 filings have been published. The latest transaction was filed on 1 April 2022 — Levée d'options. Regulator: SEC (Form 4). The full history is openly available.
Declarations8 total
€41,0917,621 shares@ €5.39180.051% mcap37.4% of flow
Common Stock
SEC:0001209191-22-023285:0·
016,000 shares0
Common Stock
SEC:0001209191-22-010483:0·
016,000 shares0
Common Stock
SEC:0001209191-22-006142·
016,000 shares0
Common Stock
SEC:0001209191-22-006142:0·
080,000 shares0
Common Stock
SEC:0001209191-21-059571·
080,000 shares0
Common Stock
SEC:0001209191-21-059571:0·
€34,3606,983 shares@ €4.92050.043% mcap100.0% of flow
Common Stock
SEC:0001209191-21-039073·
€34,3606,983 shares@ €4.92050.043% mcap31.3% of flow
Common Stock
SEC:0001209191-21-039073:0·
8 of 8 declarations
About Galimi Francesco
Galimi Francesco serves as SVP & Chief Medical Officer at Adicet Bio, Inc. He is responsible for the company's medical strategy and clinical research. His role is essential in ensuring that products meet safety and efficacy standards.
